An interventional study of SPIN exercise-training and Control Condition (WELL) in Multiple Sclerosis, sponsored by The University of Texas Health Science Center, Houston. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Supportive care
The purpose of this study is to assess changes in the outcome of exercise behavior between the SPIN exercise-training condition and the WEllness for Longevity Living (WELL) attention/contact wellness control condition and to examine differences in exercise behavior, functioning, disability, and health between the SPIN and WELL conditions
3,524 studies on the registry are indexed under Multiple Sclerosis; 668 are open to participants now.
This study's planned enrollment of 100 is above the median of 50 across 2,386 interventional studies indexed under Multiple Sclerosis.
Browse Multiple Sclerosis studies →The University of Texas Health Science Center, Houston is the lead sponsor of 897 studies on the registry; 214 are open to participants now.
Of its 173 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: SPIN exercise-training
Behavioral: Control Condition (WELL)
Participants complete three days of both modalities each week, with at least one day of rest between resistance sessions. For the first two weeks, all participants begin at 10-minute aerobic sessions and 1 set of 10 repetitions of five resistance exercises. The aerobic goal is to progress to 30-minute sessions (90 minutes/week) using a cycle (arm) ergometer; the resistance goal is 2 sets of 15 repetitions of 10 exercises (\~60 minutes/week). After two weeks, participants select one of three progression tracks (white, blue, or orange) with their coach. The final overall goal is 30 minutes of aerobic exercise plus 10 resistance exercises for two sets of 15 repetitions, three days per week (\~150 minutes/week of MVPA).The total time is 16 weeks.
The WELL attention/contact control mirrors SPIN in coaching schedule and materials but focuses on health behaviors other than physical activity (diet, emotions, stress, sleep, fatigue, and falls). It is based on Social Cognitive Theory (SCT) principles and integrates National Multiple Sclerosis Society (NMSS) wellness resources. WELL includes 12 newsletters (Diet, Sleep, Stress, Balance, Cognition, and Fatigue).
Change in self reported total minutes per week of moderate-to-vigorous physical activity (MVPA)
Time frame: Baseline , 16 weeks.
Change in strength training, assessed by the Leisure Time Physical Activity Questionnaire for People with Disabilities (LTPAQ-D)
Participants report the number of days and average minutes per day spent in mild-, moderate-, and vigorous-intensity aerobic activities during the previous 7 days. Weekly minutes are calculated separately for each intensity and summed to obtain total aerobic physical activity, expressed in minutes per week. Higher values indicate greater participation in leisure-time aerobic physical activity
Time frame: Baseline , 16 weeks
Change in device-measured exercise behavior
Physical activity is measured using an ActiGraph GT3X+ triaxial accelerometer worn on the non-dominant wrist for 7 consecutive days. Acceleration data from the three axes are combined to derive vector magnitude activity counts. Total vector magnitude activity counts are calculated using the study-specified accelerometer data processing and aggregation methods.
Time frame: Baseline , 16 weeks
Change in Upper-limb function as assessed by the Nine-Hole Peg Test
Upper-limb dexterity is assessed using the Nine-Hole Peg Test (NHPT). Participants are instructed to place nine pegs into a pegboard and remove them as quickly as possible. Performance is measured by the time required to complete the task, recorded in seconds. A decrease in completion time indicates improved manual dexterity.
Time frame: Baseline , 16 weeks
Change in Upper-limb function as assessed by the Grip strength using the hand dynamometer
Grip strength is assessed using a hand dynamometer. Participants squeeze the dynamometer according to the study protocol, and grip strength is recorded in kilograms s. An increase in grip strength indicates improved grip force.
Time frame: Baseline , 16 weeks
Change in Disability / Activities of Daily Living ( ADL) as assessed by the Barthel Index score
The Barthel Index will be used to assess changes in participants' independence in activities of daily living (ADLs), including feeding, bathing, grooming, dressing, bowel and bladder control, toilet use, transfers, mobility, and stair climbing. Total scores range from 0 to 100 with higher scores indicating greater independence and lower scores indicating greater dependence.
Time frame: Baseline , 16 weeks
Change in Health-Related Quality of Life as assessed by the Multiple Sclerosis Impact Scale-29 (MSIS-29)
The Multiple Sclerosis Impact Scale-29 (MSIS-29) is a 29-item, patient-reported outcome measure that assesses the physical and psychological impact of multiple sclerosis on health-related quality of life. The scale includes 20 physical-impact items and 9 psychological-impact items. Scores are transformed to a 0-100 scale, with higher scores indicating greater impact of multiple sclerosis and worse health-related quality of life.
Time frame: Baseline , 16 weeks
Start is estimated for Jan 2027; primary completion for Jan 2029, 23 months later.
Of 868 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 23 months is close to that.
Counting every sponsor, half of 889 studies reached it within 21 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston →